109 related articles for article (PubMed ID: 38212294)
21. Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma.
Zhang P; Wang W; Liu L; Li H; Sha X; Wang S; Huang Z; Zhou Y; Shi J
Sci Rep; 2022 Dec; 12(1):22077. PubMed ID: 36543847
[TBL] [Abstract][Full Text] [Related]
22. Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma.
Yang Q; Zhu W; Gong H
Front Immunol; 2023; 14():1148483. PubMed ID: 37077919
[TBL] [Abstract][Full Text] [Related]
23. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
[TBL] [Abstract][Full Text] [Related]
24. Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma.
Guo Z; Hu L; Wang Q; Wang Y; Liu XP; Chen C; Li S; Hu W
Curr Oncol; 2023 Feb; 30(3):2845-2861. PubMed ID: 36975430
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma.
Yang C; Wei Y; Li W; Wei J; Chen G; Xu M; Liu G
J Immunol Res; 2022; 2022():6567916. PubMed ID: 35571564
[TBL] [Abstract][Full Text] [Related]
26. Risk factors analysis and survival prediction model establishment of patients with lung adenocarcinoma based on different pyroptosis-related gene subtypes.
Wen Z; Pei B; Dai L; Lu P; Li X; Zhang C; Ge S
Eur J Med Res; 2023 Dec; 28(1):601. PubMed ID: 38111060
[TBL] [Abstract][Full Text] [Related]
27. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of immune-related genes and comparative analysis of immune cell infiltration in lung adenocarcinoma: sex differences.
Fan T; Li C; He J
Biol Sex Differ; 2021 Dec; 12(1):64. PubMed ID: 34863300
[TBL] [Abstract][Full Text] [Related]
29. Development of a copper metabolism-related gene signature in lung adenocarcinoma.
Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S
Front Immunol; 2022; 13():1040668. PubMed ID: 36524120
[TBL] [Abstract][Full Text] [Related]
30. Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.
Liu ZT; Shen JT; Lei YJ; Huang YC; Zhao GQ; Zheng CH; Wang X; Wang YT; Chen L; Li ZX; Li SZ; Liao J; Yu TD
BMC Cancer; 2023 Nov; 23(1):1141. PubMed ID: 38001428
[TBL] [Abstract][Full Text] [Related]
31. Molecular Typing Based on Oxidative Stress Genes and Establishment of Prognostic Characteristics of 7 Genes in Lung Adenocarcinoma.
Tu J; Tang M; Li G; Chen L; Huang Y
Oxid Med Cell Longev; 2022; 2022():9683819. PubMed ID: 36148413
[TBL] [Abstract][Full Text] [Related]
32. Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes.
Zhang Y; Qin W; Zhang W; Qin Y; Zhou YL
Clin Transl Oncol; 2023 Apr; 25(4):959-975. PubMed ID: 36447119
[TBL] [Abstract][Full Text] [Related]
33. A New Prognostic Indicator of Immune Microenvironment and Therapeutic Response in Lung Adenocarcinoma Based on Peroxisome-Related Genes.
Xiong Z; Zhang L; Fan W
J Immunol Res; 2022; 2022():6084589. PubMed ID: 35935579
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of genes related to cancer-associated fibroblasts in lung adenocarcinoma.
Peng J; He C; Yan H; Zhou W
Technol Health Care; 2023; 31(6):2339-2354. PubMed ID: 37661904
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
38. A novel metabolic-immune related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.
Tang X; Qi C; Zhou H; Liu Y
Heliyon; 2022 Aug; 8(8):e10164. PubMed ID: 36016532
[TBL] [Abstract][Full Text] [Related]
39. Immune Cell Infiltration and Clinical Significance of Angiogenesis-related Genes in Lung Adenocarcinoma.
Zhao QI; Ren W; Gao S; Mu N
Anticancer Res; 2023 Oct; 43(10):4473-4489. PubMed ID: 37772547
[TBL] [Abstract][Full Text] [Related]
40. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
